Lineage Decision-Making within Normal Haematopoietic and Leukemic Stem Cells

Int J Mol Sci. 2020 Mar 24;21(6):2247. doi: 10.3390/ijms21062247.

Abstract

To produce the wide range of blood and immune cell types, haematopoietic stem cells can "choose" directly from the entire spectrum of blood cell fate-options. Affiliation to a single cell lineage can occur at the level of the haematopoietic stem cell and these cells are therefore a mixture of some pluripotent cells and many cells with lineage signatures. Even so, haematopoietic stem cells and their progeny that have chosen a particular fate can still "change their mind" and adopt a different developmental pathway. Many of the leukaemias arise in haematopoietic stem cells with the bulk of the often partially differentiated leukaemia cells belonging to just one cell type. We argue that the reason for this is that an oncogenic insult to the genome "hard wires" leukaemia stem cells, either through development or at some stage, to one cell lineage. Unlike normal haematopoietic stem cells, oncogene-transformed leukaemia stem cells and their progeny are unable to adopt an alternative pathway.

Keywords: cancer; haematopoiesis; leukaemia; lineage decision making; oncogenes; stem cells.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Lineage*
  • Gene Expression Regulation, Neoplastic
  • Hematopoiesis*
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Leukemia / blood*
  • Leukemia / genetics
  • Neoplastic Stem Cells / cytology
  • Neoplastic Stem Cells / metabolism